en · de · es
cardarine-notes.peptides1004.com › Faq › Cardarine As Investigational Pparδ Agonist — Beginner to Advanced

Cardarine As Investigational Pparδ Agonist — Beginner to Advanced

By Editorial Desk · published 2026-07-03 · last reviewed 2026-08-01 · Faq

prohibited list raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.

Cardarine as Investigational PPARδ Agonist

Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.

Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.

The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.

Regulation and Detection

Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.

Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.

Cardarine at a glance

PropertyValueNotes
Common synonymsGW501516, GW-501516, GW 501516, endurobolNames vary in research and anti-doping documents.
Chemical classSynthetic PPARδ agonistSmall-molecule nuclear receptor ligand.
CAS Registry Number317318-70-0Identifier commonly associated with GW501516.
AppearanceWhite to off-white powderTypical for purified research material.
SolubilityLow in water; soluble in DMSO and ethanolOrganic solvents are common for laboratory stock solutions.

Identity and Pharmacological Classification

Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.

Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.

Related pages on this site

Regulation and Analytical Detection

Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.

Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.

Background from the literature

The molecular mass (m) is the mass of a given molecule: it is usually measured in daltons (Da or u). Different molecules of the same compound may have different molecular masses because they contain different isotopes of an element. This is distinct but related to the molar mass, which is a measure of the average molecular mass of all the molecules in a sample and is usually the more appropriate measure when dealing with macroscopic (weigh-able) quantities of a substance. Molecular masses are calculated from the atomic masses of each nuclide, while molar masses are calculated from the standard atomic weights of each element. The standard atomic weight takes into account the isotopic distribution of the element in a given sample (usually assumed to be "normal"). For example, water has a molar mass of 18.0153(3) g/mol, but individual water molecules have molecular masses which range between 18.0105646863(15) Da (1H216O) and 22.0277364(9) Da (2H218O). The distinction between molar mass and molecular mass is important because relative molecular masses can be measured directly by mass spectrometry, often to a precision of a few parts per million. This is accurate enough to directly determine the chemical formula of a molecule.

This work led to the first successful sequence-based analysis of the genomes of single cancer cells from tumors by Wigler's then-graduate student Nick Navin, and subsequently, tumor cells in circulation by Wigler's collaborator Jim Hicks. In the early 2000s, Wigler, Jonathan Sebat and Lakshmi Muthuswamy began copy number analysis of healthy individuals, leading to the discovery of a new source of genetic variability, copy number variations or CNVs. The abundance of CNVs in the human genome is a major source of individual variation. The team at CSHL then continued this line of work to demonstrate that spontaneous germ-line mutation is likely to be a major cause for autism. Their observations and theories about autism provide a now widely accepted approach for understanding other human mental and physical abnormalities.

=== Adhesive organ === On the terminal region of the 5th tarsal segment, the C. vomitoria contain pulvilli, which are the cushion-like hairy feet on insects and many arthropods located at base of their two claws. The hair that project from the ventral surface is the key for the adhesion abilities of these flies. Additionally, they have large claws that help to hold on to irregular surfaces to prevent falling. Calliphora vomitoria, like other blowflies, also secrete non-volatile lipids through the hairs that are important for further adhesion. By a combination of the physical grip of the claws and hairs and the surface tension created by the lipid secretions, they are able to adhere to smooth surfaces with ease.

After his abdication on 14 December 1918, Ukrainian hetman Pavlo Skoropadskyi emigrated to Germany. From there he led the so-called Hetman movement (Ukrainian: Гетьманський рух), which consisted of a number of Ukrainian conservative monarchist organizations from different groups of Ukrainian diaspora. Most prominent of these organizations were the Ukrainian Union of Agrarians-Statists (Ukrainian: Український союз хліборобів-державників) founded in Vienna by Vyacheslav Lypynskyi and Serhiy Shemet, and the United Hetman Organization (Ukrainian: Союз гетьманців державників) active in Canada and the United States. In his "Letters to Brothers Agrarians", published in 1926, Lypynskyi elaborated the idea of an independent, classocratic, pan-Ukrainian "toilers' monarchy" without political parties, ruled by hetman and his dynasty with the help of an agrarian aristocracy and the co-operation of the productive classes. In Canada and the United States the Hetman movement emerged from the pre-WW1 Sich scouting societies and was implicitly supported by the Ukrainian Greek-Catholic Church. The movement supported the re-establishment of the Hetman state of Pavlo Skoropadskyi and devoted a lot of energy to military training of Ukrainian émigrés for the future liberation of their homeland, going as far as to acquire a number of airplanes. In 1940 the Canadian branch of the organization became one of the founders of the Ukrainian Canadian Congress.

Sources: en.wikipedia.org

Reference notes

=== Brand names === Other brand names include Zadex (Hungary), Rheutrop (Austria), Acemetadoc, Acephlogont, Azeat, Rantudil (Germany, Hungary, Mexico, Poland, Portugal, Turkey), Gamespir (Greece), Oldan, Reudol (Spain), Tilur (Switzerland), ACEO (Taiwan), Ost-map (Egypt).

In statistical copolymers the sequence of monomer residues follows a statistical rule. If the probability of finding a given type monomer residue at a particular point in the chain is equal to the mole fraction of that monomer residue in the chain, then the polymer may be referred to as a truly random copolymer (structure 3). Statistical copolymers are dictated by the reaction kinetics of the two chemically distinct monomer reactants, and are commonly referred to interchangeably as "random" in the polymer literature. As with other types of copolymers, random copolymers can have interesting and commercially desirable properties that blend those of the individual homopolymers. Examples of commercially relevant random copolymers include rubbers made from styrene-butadiene copolymers and resins from styrene-acrylic or methacrylic acid derivatives. Copolymerization is particularly useful in tuning the glass transition temperature, which is important in the operating conditions of polymers; it is assumed that each monomer occupies the same amount of free volume whether it is in a copolymer or homopolymer, so the glass transition temperature (Tg) falls between the values for each homopolymer and is dictated by the mole or mass fraction of each component. A number of parameters are relevant in the composition of the polymer product; namely, one must consider the reactivity ratio of each component. Reactivity ratios describe whether the monomer reacts preferentially with a segment of the same type or of the other type.

=== Optic neuritis === HHV-6 induced ocular inflammation has been reported three times. All three were reported in elderly individuals, two during 2007 and one during 2011. The first two were reported in Japan and France, the most recent one in Japan. These were believed to have occurred as a result of a reactivation, as anti-HHV-6 IgM antibody levels were low.

=== Surgery === As thymomas are seen in 10% of all people with the MG, they are often given a chest X-ray and CT scan to evaluate their need for surgical removal of their thymus glands and any cancerous tissue that may be present. Even if surgery is performed to remove a thymoma, it generally does not lead to the remission of MG. Surgery in the case of MG involves the removal of the thymus, although in 2013, no clear benefit was indicated except in the presence of a thymoma. A 2016 randomized, controlled trial, however, found some benefits.

1993/974) Road Traffic Act 1991 (Commencement No. 6) Order 1993 (S.I. 1993/975) Protection of Wrecks (Designation No. 1) Order 1993 (S.I. 1993/976) Banking Appeal Tribunal (Amendment) Regulations 1993 (S.I. 1993/982) Building Societies Appeal Tribunal (Amendment) Regulations 1993 (S.I. 1993/983) Building Societies (Prescribed Contracts) Order 1993 (S.I. 1993/984) Building Societies (Designation of Qualifying Bodies) Order 1993 (S.I. 1993/985) Sale of Registration Marks (Amendment) Regulations 1993 (S.I. 1993/986) Retention of Registration Marks Regulations 1993 (S.I. 1993/987) Retention of Registration Marks Regulations 1992 (Amendment) Regulations 1993 (S.I. 1993/988) Building Societies (Designation of Qualifying Bodies) (No. 2) Order 1993 (S.I. 1993/989) Animals, Meat and Meat Products (Examination for Residues and Maximum Residue Limits) (Amendment) Regulations 1993 (S.I. 1993/990) Tayside Region (Electoral Arrangements) Order 1993 (S.I. 1993/991) Dumfries and Galloway Region (Electoral Arrangements) Order 1993 (S.I. 1993/992) National Health Service (Appointment of Consultants) (Scotland) Regulations 1993 (S.I. 1993/994) Assured Tenancies (Exceptions) (Scotland) Amendment Regulations 1993 (S.I. 1993/995) Environmentally Sensitive Areas (Central Southern Uplands) Designation Order 1993 (S.I. 1993/996) Environmentally Sensitive Areas (Western Southern Uplands) Designation Order 1993 (S.I. 1993/997) Education (School Curriculum and Related Information) (Amendment) (Wales) Regulations 1993 (S.I. 1993/998)

Sources: en.wikipedia.org

Frequently asked questions

What is cardarine?

Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.

Is cardarine a steroid?

No. Cardarine is not a steroid hormone; it targets the nuclear receptor PPARδ. Its classification in anti-doping rules differs from anabolic steroids, though it remains prohibited in sport.

Why was cardarine not developed further?

Early rodent studies reported tumor formation at multiple sites, which raised safety concerns. Sponsors stopped clinical development, and no approved human product exists.

Is cardarine legal?

Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.

Network